The loss of GW Pharmaceuticals Plc under GAAP for 9 months of 2020 amounted to $28.981 million, compared to a profit of $ 15.927 million in the previous year. Revenue increased 87.4% to $378.983 million, compared to $202.256 million a year earlier.
The loss of GW Pharmaceuticals Plc under GAAP for 9 months of 2020 amounted to $28.981 million, compared to a profit of $ 15.927 million in the previous year. Revenue increased 87.4% to $378.983 million, compared to $202.256 million a year earlier. 
ir.gwpharm.com
English (US) 